Optavia
May 26, 2026
BALTIMORE, Md. -- May 26, 2026
Medifast said its board has appointed President Nicholas Johnson as chief executive officer effective June 1, 2026, completing the succession plan announced in January when Dan Chard said he would move to non-executive chairman.
Johnson's offer letter sets annual base salary at 600,000 dollars, a target bonus of 100% of base salary and a long-term incentive target of 250% of base salary. He joined Medifast in 2018 as Optavia USA market president, later led coach and client experience and field operations, and became company president in early 2026. Chard's shift to non-executive chairman is not due to any disagreement with management or the board, the company said.
Optavia is Medifast's coach-led weight-management brand.